SMTI Financials: Sanara Medtech Inc AI Analysis



Financials

SMTI Financial

Sanara Medtech Inc

$19.72

3.84%

$0.73

At close: May 01, 16:00:00 GMT-4

$19.72

Post-market: May 01, 16:11:10 GMT-4

Overview Forecast Earnings Dividends Financials

Key Stats

Prev.Close

$18.99

Open

$19.2

Day's Range

$18.61 - $19.8

52 week range

$16.46 - $35.95

Volume

20.1K

Avg.Volume

58.9K

Dividend yield

EPS (TTM)

-4.35

Market Cap

$180.8M

What is SMTI?

Sanara MedTech, Inc.engages in the development, marketing, and distribution of biotechnology products to physicians, hospitals, and clinics. The company is headquartered in Fort Worth, Texas and currently employs 141 full-time employees. The company markets several products for surgical and chronic wound care applications and has multiple products in its pipeline. Its surgical products, CellerateRX Surgical, TEXAGEN, BiFORM, ACTIGEN, ALLOCYTE, ALLOCYTE Plus Advanced Viable Bone Matrix (ALLOCYTE Plus), BIASURGE, FORTIFY TRG Tissue Repair Graft (FORTIFY TRG), and FORTIFY FLOWABLE Extracellular Matrix (FORTIFY FLOWABLE) are used in a range of surgical specialties to help promote patient healing and reduce the risk of complications. CellerateRX Surgical products, TEXAGEN products, FORTIFY TRG and FORTIFY FLOWABLE are used in specialties, including cardiothoracic, colorectal, general surgery, hand, head and neck, high-risk obstetrics and gynecology, Mohs surgery, neurosurgery, and others.

Features

Markets

News

Income

Balance sheet

Cash flow

Annual

Quarterly

SMTI Income

Financials in millions USD. Fiscal year is February - January.

Breakdown	TTM	12/31/2025	09/30/2025	06/30/2025	03/31/2025	12/31/2024
Revenue	103	27	26	25	23	26
Revenue Growth (YoY)	20%	4%	24%	25%	28%	53%
Cost of Revenue	7	1	1	1	1	2
Gross Profit	95	25	24	23	21	24
Selling, General & Admin	82	20	19	21	21	21
Research & Development	5	2	1	1	1	2
Operating Expenses	91	22	21	23	23	23
Other Non Operating Income (Expenses)	--	--	--	--	--	--
Pretax Income	-5	-1	0	-2	-3	-1
Income Tax Expense	--	--	--	--	--	--
Net Income	-37	-1	-30	-2	-3	-1
Net Income Growth	311%	0%	1,400%	-33%	200%	--
Shares Outstanding (Diluted)	8.66	8.66	8.64	8.61	8.57	8.53
Shares Change (YoY)	2%	2%	1%	2%	2%	2%
EPS (Diluted)	-4.33	-0.18	-3.51	-0.23	-0.41	-0.18
EPS Growth	280%	0%	932%	-43%	96%	537%
Free Cash Flow	2	3	1	0	-3	0
Free Cash Flow Per Share	--	--	--	--	--	--
Gross Margin	92.23%	92.59%	92.3%	92%	91.3%	92.3%
Operating Margin	2.91%	7.4%	7.69%	0%	-8.69%	0%
Profit Margin	-35.92%	-3.7%	-115.38%	-8%	-13.04%	-3.84%
Free Cash Flow Margin	1.94%	11.11%	3.84%	0%	-13.04%	0%
EBITDA	6	2	2	1	-1	1
EBITDA Margin	5.82%	7.4%	7.69%	4%	-4.34%	3.84%
D&A For EBITDA	3	0	0	1	1	1
EBIT	3	2	2	0	-2	0
EBIT Margin	2.91%	7.4%	7.69%	0%	-8.69%	0%
Effective Tax Rate	--	--	--	--	--	--

Follow-Up Questions

What are Sanara Medtech Inc's key financial statements?



According to the latest financial statement (Form-10K), Sanara Medtech Inc has a total asset of $0, Net loss of $0

What are the key financial ratios for SMTI?



Sanara Medtech Inc's Current ratio is 0, has a Net margin is 0, sales per share of $0.

How is Sanara Medtech Inc's revenue broken down by segment or geography?



Sanara Medtech Inc largest revenue segment is Soft Tissue Repair Products, at a revenue of 54,836,410 in the most earnings release.For geography, United States is the primary market for Sanara Medtech Inc, at a revenue of 64,989,841.

Is Sanara Medtech Inc profitable?



no, according to the latest financial statements, Sanara Medtech Inc has a net loss of $0

Does Sanara Medtech Inc have any liabilities?



no, Sanara Medtech Inc has liability of 0

How many outstanding shares for Sanara Medtech Inc?



Sanara Medtech Inc has a total outstanding shares of 0

Sanara Medtech Inc (SMTI) Financial

SMTI Stock Price Chart